Comparing A-Linker and Walker for Mobility After Knee Surgery
Observation of Wheeled Device Use After TKA
This study is testing whether using a new mobility device called the A-Linker helps people move better after knee surgery compared to using a standard walker.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 19 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Redwood City, California) |
| Trial ID | NCT06080152 on ClinicalTrials.gov |
What this trial studies
This pilot study investigates the impact of two mobility devices, the A-Linker and a standard walker, on patient maneuverability and mobility following total knee arthroplasty. Patients are randomized into two groups, with one group using the A-Linker and the other using a walker for three months prior to their surgery. The study will assess changes in mobility through questionnaires administered at various intervals: at the start, six weeks, twelve weeks, and eighteen weeks post-surgery. The goal is to determine if the A-Linker offers significant advantages over traditional walkers in improving mobility outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals scheduled to receive total knee arthroplasty.
Not a fit: Patients who are not undergoing total knee arthroplasty will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance mobility recovery for patients undergoing total knee arthroplasty.
How similar studies have performed: While this approach is innovative, similar studies have not been widely reported, making this a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any person receiving Primary Total Knee Arthroplasty, ages 18-99 * Patient is mobile with no more than a single cane/single crutch assist preoperatively Exclusion Criteria: * Any person not receiving knee arthroplasty, ages under 18 or greater than 99 * Patient requires simultaneous or staged bilateral replacements, staged \<90 days apart. * Patients who have active claudication from a lumbar stenosis or peripheral vascular disease
Where this trial is running
Redwood City, California
- 450 Broadway — Redwood City, California, United States (Recruiting)
Study contacts
- Study coordinator: Derek Amanatullah, MD
- Email: DFA@stanford.edu
- Phone: (650) 723-2257
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.